Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0L1ZK
|
|||
| Former ID |
DNCL001860
|
|||
| Drug Name |
MDCO-216
|
|||
| Indication | Arteriosclerosis [ICD-11: BD40; ICD-10: I70] | Phase 1 | [1] | |
| Acute coronary syndrome [ICD-11: BA41; ICD-9: 411.1] | Preclinical | [1] | ||
| Company |
The Medicines Company
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800012886) | |||
| REF 2 | MDCO-216 (Apo A-I Milano/POPC Complex) Administered to Cynomolgus Monkeys Induces Pronounced Changes in Plasma Lipids and Apolipoproteins. Circulation. 2011; 124: A10978. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.